Quest for life on MARS: Mission incomplete

Journal of Pediatric Gastroenterology and Nutrition

Volumn 58, Issue 2, 2014, Pages 140-141

  Jain, V ^a   Dhawan, A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER;

BLOOD; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATOLENTICULAR DEGENERATION; HUMAN; LIVER; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; RENAL REPLACEMENT THERAPY;

COPPER; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; RENAL DIALYSIS;

EID: 84894177807     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3182a85283     Document Type: Note

References (12)

1. Rustom N, Bost M, Cour-Andlauer F, et al. Effect of molecular adsorbents recirculating system treatment in children with acute liver failure caused by Wilson disease. J Pediatr Gastroenterol Nutr 2014;58:160-4.
2. Heemann U, Treichel U, Loock J, et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. J Hepatol 2002;36 (4 pt 1):949-58.
3. Hassanein TI, Tofteng F, Brown RS Jr et al. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 2007;46:1853-62.
4. Mitzner SR, Stange J, Klammt S, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000;6:277-86.
5. Schmidt LE, Wang LP, Hansen BA, et al. Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transpl 2003;9:290-7.
6. Sen S, Felldin M, Steiner C, et al. Albumin dialysis and molecular adsorbents recirculating system (MARS) for acute Wilson's disease. Liver Transpl 2002;8:962-7.
7. Kreymann B, Seige M, Schweigart U, et al. Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatol 1999;31:1080-5.
8. Collins KL, Roberts EA, Adeli K, et al. Single pass albumin dialysis (SPAD) in fulminant Wilsonian liver failure: a case report. Pediatr Nephrol 2008;23:1013-6.
9. Banares R, Nevens F, Larsen FS, et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology 2013;57:1153-62.
10. Saliba F, Camus C, Durand F Randomized controlled multicentre trial evaluating the efficacy and safety of albumin dialysis with MARS in patients with fulminant and subfulminant hepatic failure. Hepatology 2008;48 (suppl 4):377.
11. Dhawan A, Taylor RM, Cheeseman P, et al. Wilson's disease in children: 37-year experience and revised King's score for liver transplantation. Liver Transpl 2005;11:441-8.
12. Auth MK, Kim HS, Beste M, et al. Removal of metabolites, cytokines and hepatic growth factors by extracorporeal liver support in children. J Pediatr Gastroenterol Nutr 2005;40:54-9.